PALI
#3394
Palisade Bio, Inc. - Common Stock
1.4 6 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.35%
Variación mensual
-32.72%
Variación en los últimos 6 meses
-22.34%
Cambio anual
-14.12%
Cierres anteriores
1.4 8
Open
1.4 7
Mínimo
1.3 8
Máximo
1.4 7
Financials
- Market Capitalization 254.44 M
- Employee 14
- Founded 2005
- CEO N/A
- Website www.palisadebio.com
- Headquarter Delaware, United States
- FIGI BBG000QG4DJ2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.83
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3372 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.03 USD | +8.42% | +7.29% | -8.04% | -40.01% | 260.49 M USD | ||
| 3392 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -0.93% | -7.39% | -14.11% | +40.13% | 255.22 M USD | ||
| 3401 |  IPSC Century Therapeutics, Inc. - Common Stock | 1.46 USD | +14.06% | -9.32% | -29.47% | +143.33% | 264.37 M USD | ||
| 3422 |  IMRX Immuneering Corporation - Class A Common Stock | 3.73 USD | -3.37% | -7.44% | -21.31% | -43.83% | 241.32 M USD |